#Clinical Infectious Diseases

Individuals taking the newest HCV treatments are often at risk of clinically significant drug-drug interactions with other medications.

Using hepatitis C core-antigen testing to screen for acute cases among HIV-positive people is reliable and saves resources compared with PCR t...

While people with HIV are typically tested for hepatitis C upon entering care, follow-up hep C screens are less common.

As prescription drug abuse leads more Americans on a path to heroin, new cases of hepatitis C are rising among young people in non-urban areas...

Drinking even moderately is linked to a much higher risk of advanced liver fibrosis among those coinfected with hepatitis C and HIV.

Those coinfected with hepatitis C and HIV who have advanced fibrosis should receive hep C therapy, because of the risk of developing liver dec...

People with cirrhosis who are cured of hepatitis C have significantly lowered risk of liver decompensation, liver cancer and death.

Viread (tenofovir) and Epivir (lamivudine) lower the risk of infection with hepatitis B among HIV-positive gay men who havenâ€™t been vac...

Hep C treatment for those coinfected with HIV who have compensated cirrhosis helps prevent decompensated cirrhosis and lowers the risk of deat...

Sexual transmission and non-injection drug use may be to blame for high levels of hepatitis C infection among HIV-positive gay men at a Boston...

A large study has underscored that the hepatitis B and C viruses disproportionately affect baby boomers.

Spanish researchers have sounded the alarm that rates of liver cancer are rising dramatically among people with HIV, solely as a result of vir...